Mr. William Dent Mckinney Jr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Mack Lane, Belleview, MO 63623 Phone: 573-697-5818 Fax: 573-697-5820 |
News Archive
A new study published on the preprint server bioRxiv reports the elucidation of the mechanism of inhibition of SARS-CoV-2 by a non-nucleotide inhibitor called suramin. This is the first such compound to be shown to have such activity and shows promise for use as a repurposed drug against COVID-19.
Breast cancer is the second leading cause of cancer deaths among women in the United States. Many of these deaths occur when there is an initial diagnosis of invasive or metastatic disease. A protein called NEDD9-which regulates cell migration, division and survival-has been linked to tumor invasion and metastasis in a variety of cancers.
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has completed the treatment portion, including all protocol-allowed retreatments of all patients, of its Phase 2 clinical trial of PV-10 for metastatic melanoma. The study involved treatment of 80 subjects with Stage III or Stage IV metastatic melanoma.
At a news conference opening the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention on Sunday in Cape Town, South Africa, Julio Montaner, president of the International AIDS Society, expressed disappointment that the "G8 ignored the HIV-AIDS issue at its annual summit this month," which was "just four years after pledging at the 2005 Gleneagles [G8] summit to fight for universal access to AIDS treatment by 2010," the Globe and Mail reports.
› Verified 2 days ago